Bristol-Myers Squibb Cancer Moves And Equity Efforts Underpin Valuation Case [Yahoo! Finance]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Yahoo! Finance
Janux Therapeutics has nominated a new tumor activated therapeutic candidate under its collaboration with Bristol-Myers Squibb, triggering a milestone for the partnership. The candidate targets a broad range of solid tumors, with Bristol-Myers Squibb preparing for potential clinical development and future commercialization. Separately, Bristol-Myers Squibb is expanding its Standing in the Gaap program in multiple myeloma, launching a survey to better understand care barriers and inequities in the US. For investors tracking NYSE:BMY, these updates come as the stock trades around $59.6, with a value score of 4 and a mixed return profile. The shares show an 11.5% return year to date and 9.4% over the past year, alongside a 3-year return of a 3.2% decline and a 5-year return of 17.7%. The new oncology candidate and the expanded health equity work in multiple myeloma provide additional information about how Bristol-Myers Squibb is putting capital and partnerships to work. These de
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks [Yahoo! Finance]Yahoo! Finance
- Coya Therapeutics Announces Planned Board Transition and Appointment of Mark H. Pavao as Independent Director [Yahoo! Finance]Yahoo! Finance
- Trump unveils up to 100% tariffs on patented drugs [Yahoo! Finance]Yahoo! Finance
- Bristol-Myers Squibb (BMY) Announces Positive Data from the Phase 3 SCOUT-HCM Trial of Camzyos [Yahoo! Finance]Yahoo! Finance
- Trump signs 100% tariff on brand-name pharmaceuticals [USA TODAY]USA TODAY
BMY
Earnings
- 2/6/26 - Beat
BMY
Sec Filings
- 4/2/26 - Form 4
- 4/2/26 - Form 4
- 4/2/26 - Form 4
- BMY's page on the SEC website